Home/Filings/4/0001104659-24-123806
4//SEC Filing

PATEL DINESH V PH D 4

Accession 0001104659-24-123806

CIK 0001377121other

Filed

Nov 26, 7:00 PM ET

Accepted

Nov 27, 7:08 PM ET

Size

13.1 KB

Accession

0001104659-24-123806

Insider Transaction Report

Form 4
Period: 2024-11-25
PATEL DINESH V PH D
DirectorPresident and CEO
Transactions
  • Sale

    Common Stock

    2024-11-26$46.25/sh21,480$993,450408,455 total
  • Exercise/Conversion

    Common Stock

    2024-11-25$21.58/sh+1,727$37,269429,935 total
  • Sale

    Common Stock

    2024-11-25$46.96/sh78,520$3,687,299435,208 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-11-251,727318,273 total
    Exercise: $21.58Exp: 2026-10-11Common Stock (1,727 underlying)
  • Gift

    Common Stock

    2024-11-257,000428,208 total
Footnotes (5)
  • [F1]The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $46.50 to $47.47. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
  • [F2]Includes an aggregate of 313 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 9, 2024.
  • [F3]On November 25, 2024, the Reporting Person made a charitable donation of 7,000 shares of common stock to a donor-advised fund, which will use the gifted shares for charitable purposes.
  • [F4]The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $44.49 to $46.50. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
  • [F5]These stock options are fully vested.

Issuer

Protagonist Therapeutics, Inc

CIK 0001377121

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001120477

Filing Metadata

Form type
4
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 7:08 PM ET
Size
13.1 KB